Dementia is a clinical syndrome involving acquired decline in cognitive functioning that is severe enough to interfere with everyday activities and represents a change from a person's previous level of functioning. It is not a single disease and is not an inevitable part of normal ageing. Memory impairment is common but is not the only defining feature; dementia can affect language, attention, reasoning, judgement, visuospatial abilities, behaviour, mood and the ability to perform familiar activities.
Different diseases can produce different patterns of cognitive decline, which is why the term dementia encompasses multiple conditions rather than identifying one pathological process. Alzheimer's disease is the most common cause, while vascular disease, dementia with Lewy bodies, frontotemporal degeneration and other neurological disorders can also produce dementia. The NHS explicitly describes dementia as a syndrome associated with ongoing decline in brain functioning and distinguishes it from normal ageing.
The causes of dementia differ at the biological level. Alzheimer's disease involves characteristic changes associated with amyloid and tau pathology, while vascular dementia results from cerebrovascular damage that disrupts brain networks. Dementia with Lewy bodies is associated with abnormal alpha-synuclein-containing Lewy bodies and often includes fluctuating cognition, visual hallucinations and parkinsonian features. Frontotemporal dementia commonly involves degeneration of frontal and temporal brain regions and can initially produce prominent behavioural, personality or language changes rather than severe memory impairment. Mixed pathology is common, particularly in older people, meaning that more than one disease process can contribute to cognitive decline. The clinical label therefore describes the syndrome while the underlying cause or causes determine the particular disease process, prognosis and treatment considerations.
Early dementia symptoms can include forgetting recent events, difficulty concentrating, trouble carrying out familiar tasks, word-finding problems, confusion about time or place and changes in mood or behaviour. These changes can initially be subtle and may overlap with normal age-related forgetfulness, depression, anxiety, medication effects, sleep problems or other medical conditions. Mild cognitive impairment is sometimes used when measurable cognitive difficulties are present but daily independence is not sufficiently affected to meet criteria for dementia.
Some people with mild cognitive impairment remain stable while others subsequently develop dementia. Diagnosis therefore requires assessment of functional impact rather than treating every memory complaint as dementia. The NHS emphasises that memory problems can have multiple causes and that dementia should not be assumed solely because someone is older.
Diagnosis involves history-taking, cognitive assessment, physical examination, review of medicines and consideration of alternative or reversible explanations. Blood and urine tests can help identify conditions that may mimic or worsen cognitive symptoms, while specialist assessment may include neuropsychological testing and brain imaging. Imaging can help identify vascular changes, structural abnormalities or patterns that support particular diagnoses, although no single scan can diagnose every form of dementia.
Information from relatives or other people who know the individual can be particularly valuable because gradual cognitive changes may not be fully recognised by the person affected. Assessment also examines daily functioning, communication, behaviour and changes over time. The purpose is not merely to assign a label but to identify the likely cause, treat contributing factors, establish support needs and allow future planning.
Dementia generally progresses over time when caused by a neurodegenerative disease, although the rate and pattern vary substantially. Later stages can involve severe memory impairment, loss of communication, reduced mobility, difficulty recognising familiar people, behavioural changes, incontinence and difficulties eating or swallowing. These effects can create risks such as falls, malnutrition, dehydration, aspiration and infections. However, progression is not identical across diseases or individuals.
Vascular dementia can show stepwise or fluctuating progression, while some neurodegenerative conditions have distinctive early behavioural, language or visuospatial features. Support consequently needs to adapt as abilities change. Maintaining familiar routines, communication methods, meaningful activities and appropriate environmental cues can help preserve function and quality of life even when cognitive impairment becomes substantial.
Treatment depends on the underlying cause. Some forms have disease-specific medicines or risk-factor management, while others have mainly symptomatic and supportive treatment. Acetylcholinesterase inhibitors such as donepezil, rivastigmine and galantamine are used for some forms of Alzheimer's disease and can also have roles in dementia with Lewy bodies and Parkinson's disease dementia. Memantine may be used in particular stages of Alzheimer's disease.
Non-drug approaches are also important and can include cognitive and environmental strategies, occupational support, physical activity where appropriate, communication assistance and carer support. There is currently no universal cure for dementia, so treatment commonly focuses on preserving function, managing symptoms, reducing avoidable complications and supporting the person and those involved in their care.
Dementia has substantial implications for autonomy, communication, employment, relationships, driving, finances, housing and healthcare decision-making. Capacity is not automatically lost at diagnosis and should be considered in relation to the specific decision and the person's ability to understand, retain, weigh and communicate relevant information. Advance planning can be useful while the person can participate fully in decisions. Carers can experience substantial practical and emotional demands, making respite, social-care assessment and appropriate professional support important components of dementia care. A diagnosis can also reduce uncertainty by allowing people to access specialist services and plan for future needs. The NHS notes that early diagnosis can help people obtain appropriate treatment and support and prepare for future changes.
Dementia should therefore be understood as a syndrome rather than a synonym for Alzheimer's disease or ordinary ageing. Its defining feature is acquired cognitive and functional decline, while the underlying causes determine the particular disease process and symptom pattern. Accurate assessment distinguishes dementia from delirium, depression, medication effects, mild cognitive impairment and other potentially reversible conditions. Management combines disease-specific treatment where available with symptom management, environmental support, rehabilitation, social care and carer support. The conceptual distinction between syndrome and cause is particularly important: Alzheimer's disease can cause dementia, but dementia itself does not identify a single pathology.
